secwatch / observer
8-K filed July 1, 2024, 7:59 PM ET CIK 0001800682
other material confidence high sentiment negative materiality 0.90

Cano Health, Inc.: going-concern / distress — Cano Health exits Chapter 11; old common stock canceled, new $211M exit financing

Cano Health, Inc.

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Eric H. Hsiao

Director
Cano Health, Inc.
Filed
July 1, 2024, 7:59 PM ET
Mark Kent, the Company’s Chief Executive Officer, has continued as a director, along with new directors, Eric H. Hsiao and Alan Wheatley.
Departed

Solomon D. Trujillo

Director
Cano Health, Inc.
Filed
July 1, 2024, 7:59 PM ET
the following directors have been deemed to have resigned from the Board in connection with the Company’s emergence from the Chapter 11 Case and pursuant to the Plan: Patricia Ferrari, Carol Flaton, Angel Morales, Dr. Alan Muney, Kim M. Rivera, and Solomon D. Trujillo.
Appointed

Alan Wheatley

Director
Cano Health, Inc.
Filed
July 1, 2024, 7:59 PM ET
Mark Kent, the Company’s Chief Executive Officer, has continued as a director, along with new directors, Eric H. Hsiao and Alan Wheatley.
Departed

Kim M. Rivera

Director
Cano Health, Inc.
Filed
July 1, 2024, 7:59 PM ET
the following directors have been deemed to have resigned from the Board in connection with the Company’s emergence from the Chapter 11 Case and pursuant to the Plan: Patricia Ferrari, Carol Flaton, Angel Morales, Dr. Alan Muney, Kim M. Rivera, and Solomon D. Trujillo.
Departed

Angel Morales

Director
Cano Health, Inc.
Filed
July 1, 2024, 7:59 PM ET
the following directors have been deemed to have resigned from the Board in connection with the Company’s emergence from the Chapter 11 Case and pursuant to the Plan: Patricia Ferrari, Carol Flaton, Angel Morales, Dr. Alan Muney, Kim M. Rivera, and Solomon D. Trujillo.
Departed

Dr. Alan Muney

Director
Cano Health, Inc.
Filed
July 1, 2024, 7:59 PM ET
the following directors have been deemed to have resigned from the Board in connection with the Company’s emergence from the Chapter 11 Case and pursuant to the Plan: Patricia Ferrari, Carol Flaton, Angel Morales, Dr. Alan Muney, Kim M. Rivera, and Solomon D. Trujillo.
Departed

Patricia Ferrari

Director
Cano Health, Inc.
Filed
July 1, 2024, 7:59 PM ET
the following directors have been deemed to have resigned from the Board in connection with the Company’s emergence from the Chapter 11 Case and pursuant to the Plan: Patricia Ferrari, Carol Flaton, Angel Morales, Dr. Alan Muney, Kim M. Rivera, and Solomon D. Trujillo.
Departed

Carol Flaton

Director
Cano Health, Inc.
Filed
July 1, 2024, 7:59 PM ET
the following directors have been deemed to have resigned from the Board in connection with the Company’s emergence from the Chapter 11 Case and pursuant to the Plan: Patricia Ferrari, Carol Flaton, Angel Morales, Dr. Alan Muney, Kim M. Rivera, and Solomon D. Trujillo.

Key facts

Extracted from this filing and checked against the source text.

Distress & Bankruptcy SEC 8-K Item 1.03 confidence 0.9

Cano Health, Inc. entered chapter 11 (petition 2024-06-28).

Proceeding
chapter 11
Petition
2024-06-28
Exact text from the filing
Also on June 28, 2024, the Plan became effective pursuant to its terms and the Debtors emerged from the Chapter 11 Cases.
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

Eric H. Hsiao was appointed as Director at Cano Health, Inc..

Action
appointed
Role
Director
Exact text from the filing
Mark Kent, the Company’s Chief Executive Officer, has continued as a director, along with new directors, Eric H. Hsiao and Alan Wheatley.
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

Solomon D. Trujillo resigned as Director at Cano Health, Inc..

Action
resigned
Role
Director
Exact text from the filing
the following directors have been deemed to have resigned from the Board in connection with the Company’s emergence from the Chapter 11 Case and pursuant to the Plan: Patricia Ferrari, Carol Flaton, Angel Morales, Dr. Alan Muney, Kim M. Rivera, and Solomon D. Trujillo.
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

Alan Wheatley was appointed as Director at Cano Health, Inc..

Action
appointed
Role
Director
Exact text from the filing
Mark Kent, the Company’s Chief Executive Officer, has continued as a director, along with new directors, Eric H. Hsiao and Alan Wheatley.
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

Kim M. Rivera resigned as Director at Cano Health, Inc..

Action
resigned
Role
Director
Exact text from the filing
the following directors have been deemed to have resigned from the Board in connection with the Company’s emergence from the Chapter 11 Case and pursuant to the Plan: Patricia Ferrari, Carol Flaton, Angel Morales, Dr. Alan Muney, Kim M. Rivera, and Solomon D. Trujillo.
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

Angel Morales resigned as Director at Cano Health, Inc..

Action
resigned
Role
Director
Exact text from the filing
the following directors have been deemed to have resigned from the Board in connection with the Company’s emergence from the Chapter 11 Case and pursuant to the Plan: Patricia Ferrari, Carol Flaton, Angel Morales, Dr. Alan Muney, Kim M. Rivera, and Solomon D. Trujillo.
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

Dr. Alan Muney resigned as Director at Cano Health, Inc..

Action
resigned
Role
Director
Exact text from the filing
the following directors have been deemed to have resigned from the Board in connection with the Company’s emergence from the Chapter 11 Case and pursuant to the Plan: Patricia Ferrari, Carol Flaton, Angel Morales, Dr. Alan Muney, Kim M. Rivera, and Solomon D. Trujillo.
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

Patricia Ferrari resigned as Director at Cano Health, Inc..

Action
resigned
Role
Director
Exact text from the filing
the following directors have been deemed to have resigned from the Board in connection with the Company’s emergence from the Chapter 11 Case and pursuant to the Plan: Patricia Ferrari, Carol Flaton, Angel Morales, Dr. Alan Muney, Kim M. Rivera, and Solomon D. Trujillo.
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

Carol Flaton resigned as Director at Cano Health, Inc..

Action
resigned
Role
Director
Exact text from the filing
the following directors have been deemed to have resigned from the Board in connection with the Company’s emergence from the Chapter 11 Case and pursuant to the Plan: Patricia Ferrari, Carol Flaton, Angel Morales, Dr. Alan Muney, Kim M. Rivera, and Solomon D. Trujillo.
View on SEC.gov
M&A Transactions SEC 8-K Item 2.01/5.01 confidence 0.9

Cano Health, Inc. underwent a change of control.

Action
change of control
Exact text from the filing
As disclosed elsewhere in this Current Report on Form 8-K, on the Effective Date, all of the Old Common Stock of the Company was cancelled and the Company issued New Equity Interests pursuant to the Plan.
View on SEC.gov
M&A Transactions SEC 8-K Item 2.01/5.01 confidence 0.7

Cano Health, Inc. completed a disposition involving holders of the Allowed First Lien Claims.

Action
disposition
Counterparty
holders of the Allowed First Lien Claims
Exact text from the filing
holders of the Allowed First Lien Claims received 100% of the New Equity Interests (subject to dilution by New Equity Interests issued in respect or as a result of (1) the MIP Equity, (2) the Participation Fee, (3) any financing fees payable in New Equity Interests in connection with the New RCF Loans and (4) the exercise of the GUC Warrants).
View on SEC.gov

Browse all distress & bankruptcy →

Source: SEC EDGAR
accession 0001193125-24-172745
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.